Cookies on this website

We use cookies to ensure that we give you the best experience on our website. If you click 'Accept all cookies' we'll assume that you are happy to receive all cookies and you won't see this message again. If you click 'Reject all non-essential cookies' only necessary cookies providing core functionality such as security, network management, and accessibility will be enabled. Click 'Find out more' for information on how to change your cookie settings.

Contact information

Email
marc.feldmann@kennedy.ox.ac.uk

Research groups

Sir Marc Feldmann FRS

Emeritus Professor

Recent publications

Anti-TNF (adalimumab) injection for the treatment of adults with frozen shoulder during the pain predominant stage protocol for a multi-centre, randomised, double blind, parallel group, feasibility trial
Journal article

Hopewell S. et al, (2022), Nihr open research, 2, 28 - 28
Identifying collagen VI as a target of fibrotic diseases regulated by CREBBP/EP300.
Journal article

Williams LM. et al, (2020), Proc natl acad sci u s a, 117, 20753 - 20763
Trials of anti-tumour necrosis factor therapy for COVID-19 are urgently needed.
Journal article

Feldmann M. et al, (2020), Lancet, 395, 1407 - 1409
Single cell force profiling of human myofibroblasts reveals a biophysical spectrum of cell states.
Journal article

Layton TB. et al, (2020), Biol open, 9
Histone H3K27me3 demethylases regulate human Th17 cell development and effector functions by impacting on metabolism.
Journal article

Cribbs AP. et al, (2020), Proc natl acad sci u s a, 117, 6056 - 6066

More publications